Semaglutide Patent War: After Dr Reddy's Blow, Novo Nordisk Moves Delhi HC Against Sun Pharma Written By Susmita Roy9 Dec 2025 5:00 PM ISTNew Delhi: In an escalation of India's unfolding GLP-1 patent war, Novo Nordisk has approached the Delhi High Court to restrain Sun Pharmaceutical...
Semaglutide Patent Clash: Delhi HC Denies Novo Nordisk Injunction, Manufacturing by Dr Reddy's to Continue Written By Susmita Roy5 Dec 2025 10:28 PM ISTNew Delhi: In a significant development in the high-stakes patent litigation over diabetes blockbuster Semaglutide, the Delhi High Court has refused...
Amycretin Shows Major HbA1c and Weight Reduction in Phase II Trial Written By Dr. Kamal Kant Kohli29 Nov 2025 12:00 PM ISTA phase II study has reported that type 2 diabetes patients treated with amycretin-a long-acting investigational GLP-1 and amylin receptor...
Novo Nordisk seeks USFDA approval for higher dose of Wegovy injection Written By Ruchika Sharma28 Nov 2025 11:30 AM ISTPlainsboro: Novo Nordisk has announced the submission of a sNDA to the U.S. Food and Drug Administration (FDA) for a higher dose of semaglutide...
CDSCO Panel Reviews Novo Nordisk's PMS Study, Clears Data on Oral Semaglutide Written By Susmita Roy22 Nov 2025 10:50 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) reviewed the Post Marketing Surveillance...
Pfizer files second lawsuit against Metsera, its controlling stockholders, Novo Nordisk Written By Ruchika Sharma4 Nov 2025 12:02 PM ISTNew York: Pfizer has announced that it has filed a second lawsuit against Metsera, its controlling stockholders, and Novo Nordisk A/S in the...
Novo Nordisk submits proposal to acquire Metsera Written By Ruchika Sharma2 Nov 2025 6:00 PM ISTDenmark: Novo Nordisk confirms that it submitted an unsolicited proposal to acquire Metsera, Inc.The acquisition of Metsera, including its early...
Pfizer files lawsuit against Metsera, its Directors and Novo Nordisk for breach of merger agreement Written By Ruchika Sharma2 Nov 2025 2:30 PM ISTNew York: Pfizer has announced that it has filed a lawsuit against Metsera, its Board of Directors, and Novo Nordisk, S.A. in the Delaware Court...
Novo Nordisk gets MHRA nod for Concizumab to prevent bleeding episodes frequency Written By Ruchika Sharma27 Oct 2025 10:30 AM ISTNovo Nordisk has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for the medicine concizumab (brand name:...
Novo Nordisk inks pact with Omeros for clinical-stage MASP-3 inhibitor zaltenibart Written By Ruchika Sharma21 Oct 2025 12:30 PM ISTDenmark: Novo Nordisk and Omeros Corporation have announced that they have entered into a definitive asset purchase and license agreement for the...
Novo Nordisk to acquire Akero Therapeutics for up to USD 5.2 billion Written By Ruchika Sharma13 Oct 2025 10:15 AM ISTDenmark: Novo Nordisk has announced that it has entered into a definitive agreement to acquire Akero Therapeutics, Inc., a publicly held...
Rs 233 Crore in 6 Months: Mounjaro Becomes India's Second-Biggest Drug by Sales Written By Farhat Nasim10 Oct 2025 3:46 PM ISTNew Delhi: In a remarkable rise, Eli Lilly's Mounjaro (tirzepatide) has become India's second-highest selling drug by value within just six months of...
